Trials / Completed
CompletedNCT01005108
Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin | Use of Gabapentin as a control intervention to evaluate the relative effects and adverse events of acupuncture for hot flashes |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2014-01-31
- Completion
- 2014-01-31
- First posted
- 2009-10-30
- Last updated
- 2020-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01005108. Inclusion in this directory is not an endorsement.